This is a StreetInsider.com Premium Only Page

Clearside Biomedical (CLSD) – StreetInsider.com Reports

Apr 16, 2024 07:06 AM Clearside Biomedical (CLSD) Appoints Anthony S. Gibney to its Board

Mar 18, 2024 07:05 AM Clearside Biomedical (CLSD) Appoints Victor Chong, M.D., MBA as Chief Medical Officer

Mar 13, 2024 07:03 AM Clearside Biomedical (CLSD) PT Lowered to $4 at Wedbush

Mar 12, 2024 04:15 PM Clearside Biomedical (CLSD) Tops Q4 EPS by 1c

Feb 7, 2024 08:01 AM Clearside Biomedical (CLSD) Prices 11.11M Share Offering at $1.35/sh

Dec 14, 2023 07:05 AM Clearside Biomedical (CLSD) Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD

Nov 13, 2023 04:12 PM Clearside Biomedical (CLSD) Tops Q3 EPS by 1c

Aug 14, 2023 04:15 PM Clearside Biomedical (CLSD) Misses Q2 EPS by 1c

Jul 31, 2023 07:06 AM Clearside Biomedical (CLSD) Highlights Excellent Safety Profile of CLS-AX and Potential for Extended Duration of Effect

Jul 10, 2023 07:06 AM Clearside Biomedical (CLSD) Announces Acceptance of Arctic Vision's NDA for Arcatus in Australia

Jun 14, 2023 06:10 AM Jones Trading Starts Clearside Biomedical (CLSD) at Buy

May 15, 2023 05:50 AM Clearside Biomedical (CLSD) Files $150M Mixed Shelf

May 11, 2023 07:14 AM Clearside Biomedical (CLSD) Misses Q1 EPS by 1c

Apr 18, 2023 07:05 AM Clearside Biomedical (CLSD) Plans ODYSSEY Phase 2b Clinical Trial of CLS-AX in Wet AMD

Mar 10, 2023 07:15 AM Clearside Biomedical (CLSD) PT Lowered to $4 at Needham & Company

Mar 10, 2023 02:37 AM Clearside Biomedical (CLSD) PT Lowered to $6 at JMP Securities

Feb 6, 2023 07:36 AM Clearside Biomedical (CLSD) Announces Leadership Team Update

Feb 2, 2023 07:05 AM Clearside Biomedical (CLSD) Reports Positive 6-Month Results from OASIS Extension Study with Suprachoroidal CLS-AX

Nov 10, 2022 07:46 AM Needham & Company Upgrades Clearside Biomedical (CLSD) to Buy

Nov 10, 2022 06:48 AM Clearside Biomedical (CLSD) PT Raised to $6 at H.C. Wainwright

Nov 10, 2022 06:35 AM Clearside Biomedical (CLSD) PT Lowered to $6 at Wedbush

Nov 9, 2022 01:12 PM Stifel Upgrades Clearside Biomedical (CLSD) to Buy

Nov 9, 2022 07:34 AM Clearside Biomedical (CLSD) Reports In-Line Q3 EPS

Nov 9, 2022 07:06 AM Clearside Biomedical (CLSD) Announces Positive Results in Safety, Durability and Biologic Effect in OASIS Phase 1/2a Clinical Trial of Suprachoroidal CLS-AX in Wet AMD Patients

Oct 4, 2022 07:06 AM Clearside Biomedical (CLSD) Presents Positive Data on Suprachoroidal Space Platform

Sep 2, 2022 02:46 AM Clearside Biomedical (CLSD) PT Lowered to $7 at JMP Securities

Aug 10, 2022 02:57 AM Clearside Biomedical (CLSD) PT Lowered to $9 at JMP Securities

Aug 9, 2022 07:37 AM Clearside Biomedical (CLSD) Reports In-Line Q2 EPS

May 12, 2022 06:13 AM Needham & Company Reiterates Hold Rating on Clearside Biomedical (CLSD)

Mar 28, 2022 06:59 AM Bausch Health Co. Inc. (BHC) and Clearside (CLSD) Announce US Launch of XIPERE

Mar 11, 2022 09:22 AM Pre-Open Stock Movers 03/11: (CLSD) (LAZY) (ALTO) Higher; (TLYS) (DOCU) (ZUMZ) Lower (more...)

Mar 11, 2022 02:04 AM Clearside Biomedical (CLSD) PT Lowered to $10 at JMP Securities

Mar 10, 2022 05:26 PM Clearside Biomedical (CLSD) Tops Q4 EPS by 15c

Mar 3, 2022 07:06 AM Clearside Biomedical (CLSD) Appoints Benjamin R. Yerxa to its Board

Jan 14, 2022 08:11 AM Clearside Biomedical (CLSD) PT Raised to $7 at Stifel

Dec 21, 2021 11:58 AM Clearside's (CLSD) CLS-AX Safety Data is a Positive, but Therapeutics Potential Remains Unclear till Phase 2 - Needham

Dec 21, 2021 07:05 AM Clearside Biomedical (CLSD) Reports Positive Safety Results from OASIS Phase 1/2a Clinical Trial of CLS-AX

Dec 15, 2021 06:21 AM Wedbush Assumes Clearside Biomedical (CLSD) at Outperform, adds to Best Ideas List

Oct 25, 2021 02:50 PM Clearside Biomedical (CLSD) PT Raised to $19 at Wedbush, Following Clinical Business Update

Oct 25, 2021 10:32 AM Clearside Biomedical (CLSD) PT Raised to $11 at JMP Securities, Following Clinical Business Update

Oct 25, 2021 06:45 AM Bausch + Lomb (BHC) and Clearside Biomedical Announce FDA Approval of XIPERE for Suprachoroidal Use for Treatment of Macular Edema Associated with Uveitis

Sep 9, 2021 07:08 AM Clearside Biomedical (CLSD) Expands XIPERE License Agreement with Arctic Vision to Include Australia, New Zealand, India and ASEAN Countries

Aug 11, 2021 03:25 AM Clearside Biomedical (CLSD) PT Raised to $10 at JMP Securities

Jul 29, 2021 06:13 AM H.C. Wainwright Starts Clearside Biomedical (CLSD) at Buy

Jul 6, 2021 09:49 AM Increasing unusual call option volume: BSQR CLSD VISL WB KDP OPTT

Jun 18, 2021 09:52 AM Clearside Biomedical (CLSD) PT Raised to $15 at Roth Capital

Jun 18, 2021 03:42 AM Increasing unusual option volume: CLSD QS SVM MNTV BCS WISH AON

Jun 17, 2021 09:30 AM Pre-Open Stock Movers 06/17: (KULR) (CLSD) (STSA) Higher; (CVAC) (CRTD) (NOVN) Lower (more...)

Jun 17, 2021 09:22 AM Clearside Biomedical (CLSD) Surges as Wedbush Triples Price Target

Jun 17, 2021 06:14 AM Clearside Biomedical (CLSD) PT Raised to $18 at Wedbush